Vivo Opportunity Fund Holdings, L.P. - 10 Mar 2026 SCHEDULE 13G Report for AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol
ANTX
Shares outstanding
35,804,325 shares
Disclosed Ownership
2,864,346 shares
Ownership
8%
Form type
SCHEDULE 13G
Filing time
13 Mar 2026, 16:02:09 UTC
Date of event
10 Mar 2026
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 8% 2,864,346 2,864,346 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC 8% 2,864,346 2,864,346 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 0.8% 289,294 289,294 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner
Vivo Opportunity Cayman, LLC 0.8% 289,294 289,294 0 /s/ Kevin Dai Kevin Dai/Managing Member